Wild-Type Mouse Models to Screen Antisense Oligonucleotides for Exon-Skipping Efficacy in Duchenne Muscular Dystrophy (vol 9, e111079, 2014)

被引：1
|
作者：
Cao, Limin
Han, Gang
Gu, Ben
Yin, HaiFang
机构：
来源：
PLOS ONE | 2018年 / 13卷 / 11期
关键词：
D O I：
10.1371/journal.pone.0207817
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页数：1
相关论文
共 9 条
  • [1] Wild-Type Mouse Models to Screen Antisense Oligonucleotides for Exon-Skipping Efficacy in Duchenne Muscular Dystrophy (vol 9, e111079, 2014)
    Cao, L.
    Han, G.
    Gu, B.
    Yin, H.
    PLOS ONE, 2019, 14 (02):
  • [2] Wild-Type Mouse Models to Screen Antisense Oligonucleotides for Exon-Skipping Efficacy in Duchenne Muscular Dystrophy
    Cao, Limin
    Han, Gang
    Gu, Ben
    Yin, HaiFang
    PLOS ONE, 2014, 9 (11):
  • [3] Optimization of antisense-mediated exon skipping in mouse models for Duchenne muscular dystrophy
    Aartsma-Rus, A.
    Heemskerk, H. A.
    de Winter, C. L.
    van Putten, M.
    De Kimpe, S.
    van Deutekom, J. C. T.
    van Ommen, G. J. B.
    NEUROMUSCULAR DISORDERS, 2008, 18 (9-10) : 757 - 757
  • [4] Systemic Antisense-Mediated Exon Skipping in Mouse Models for Duchenne Muscular Dystrophy
    Aartsma-Rus, Annemieke
    Heemskerk, Hans
    De Winter, Christa
    Van Putten, Maaike
    Janson, Anneke
    Verschuuren, Jan
    Den Dunnen, Johan
    Van Deutekom, Judith
    Van Ommen, Gert-Jan
    MOLECULAR THERAPY, 2009, 17 : S166 - S166
  • [5] Cyclic Peptides to Improve Delivery and Exon Skipping of Antisense Oligonucleotides in a Mouse Model for Duchenne Muscular Dystrophy
    Jirka, Silvana M. G.
    't Hoen, Peter A. C.
    Parillas, Valeriano Diaz
    Tanganyika-de Winter, Christa L.
    Verheu, Ruurd C.
    Aguilera, Begona
    de Visser, Peter C.
    Aartsma-Rus, Annemieke M.
    MOLECULAR THERAPY, 2018, 26 (01) : 132 - 147
  • [6] Targeting a Novel Site in Exon 51 with Antisense Oligonucleotides Induces Enhanced Exon Skipping in a Mouse Model of Duchenne Muscular Dystrophy
    Oppeneer, Todd
    Qi, Yulan
    Henshaw, Joshua
    Larimore, Kevin
    Melton, Andrew
    Puolivali, Jukka
    Carter, Caitlyn
    Fant, Pierluigi
    Brennan, Sebastian
    Wetzel, Laura A.
    Sigg, Monika A.
    Crawford, Brett E.
    Magat, Jenna
    Froelich, Steven
    Woloszynek, Josh C.
    O'Neill, Charles A.
    NUCLEIC ACID THERAPEUTICS, 2025,
  • [7] Dantrolene Enhances Antisense-Mediated Exon Skipping in Human and Mouse Models of Duchenne Muscular Dystrophy
    Kendall, Genevieve C.
    Mokhonova, Ekaterina I.
    Moran, Miriana
    Sejbuk, Natalia E.
    Wang, Derek W.
    Silva, Oscar
    Wang, Richard T.
    Martinez, Leonel
    Lu, Qi L.
    Damoiseaux, Robert
    Spencer, Melissa J.
    Nelson, Stanley F.
    Miceli, M. Carrie
    SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (164)
  • [8] Effect of different dosing regimens of exon skipping antisense oligonucleotides on functional outcome in the mdx mouse model of Duchenne muscular dystrophy
    Datson, N.
    Weij, R.
    Bijl, S.
    Janson, A.
    Vermue, R.
    Testerink, J.
    van Deutekom, J.
    NEUROMUSCULAR DISORDERS, 2015, 25 : S291 - S291
  • [9] Challenges of Assessing Exon 53 Skipping of the Human DMD Transcript with Locked Nucleic Acid-Modified Antisense Oligonucleotides in a Mouse Model for Duchenne Muscular Dystrophy
    Engelbeen, Sarah
    O'Reilly, Daniel
    van de Vijver, Davy
    Verhaart, Ingrid
    van Putten, Maaike
    Hariharan, Vignesh
    Hassler, Matthew
    Khvorova, Anastasia
    Damha, Masad J.
    Aartsma-Rus, Annemieke
    NUCLEIC ACID THERAPEUTICS, 2023, 33 (06) : 348 - 360
1